Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
Contradictory Results

Correction of the Framingham Risk Score Data Reported in SPRINT

Frederick Warner, Sanket S. Dhruva, Joseph S. Ross, Pranammya Dey, Karthik Murugiah, Harlan M. Krumholz
doi: https://doi.org/10.1101/235358
Frederick Warner
Yale School of Medicine (all), Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (Warner, Ross, Krumholz)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanket S. Dhruva
Yale School of Medicine (all), Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (Warner, Ross, Krumholz)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph S. Ross
Yale School of Medicine (all), Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (Warner, Ross, Krumholz)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pranammya Dey
Yale School of Medicine (all), Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (Warner, Ross, Krumholz)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karthik Murugiah
Yale School of Medicine (all), Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (Warner, Ross, Krumholz)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harlan M. Krumholz
Yale School of Medicine (all), Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (Warner, Ross, Krumholz)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Abstract

This report describes an error in the Framingham Risk Score data presented in the original SPRINT publication.1 The data, presented in Table 1 of the main SPRINT publication in the New England Journal of Medicine and made available to SPRINT Challenge participants, incorrectly calculated the level of baseline cardiovascular risk of the study participants using the Framingham Risk Score. The correct calculation increased the number of participants identified as having >15% 10-year risk from 5737 to 7089, a change from 61% to 76% of the total study population. This information is important for researchers attempting to validate and extend the trial’s findings and is particularly germane because the recently released American Heart Association/American College of Cardiology blood pressure guidelines changed blood pressure targets for pharmacologic therapy only for high-risk individuals.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 18, 2017.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Correction of the Framingham Risk Score Data Reported in SPRINT
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Correction of the Framingham Risk Score Data Reported in SPRINT
Frederick Warner, Sanket S. Dhruva, Joseph S. Ross, Pranammya Dey, Karthik Murugiah, Harlan M. Krumholz
bioRxiv 235358; doi: https://doi.org/10.1101/235358
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Correction of the Framingham Risk Score Data Reported in SPRINT
Frederick Warner, Sanket S. Dhruva, Joseph S. Ross, Pranammya Dey, Karthik Murugiah, Harlan M. Krumholz
bioRxiv 235358; doi: https://doi.org/10.1101/235358

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Clinical Trials
Subject Areas
All Articles
  • Animal Behavior and Cognition (4105)
  • Biochemistry (8808)
  • Bioengineering (6509)
  • Bioinformatics (23446)
  • Biophysics (11784)
  • Cancer Biology (9198)
  • Cell Biology (13314)
  • Clinical Trials (138)
  • Developmental Biology (7430)
  • Ecology (11402)
  • Epidemiology (2066)
  • Evolutionary Biology (15142)
  • Genetics (10430)
  • Genomics (14036)
  • Immunology (9167)
  • Microbiology (22142)
  • Molecular Biology (8802)
  • Neuroscience (47534)
  • Paleontology (350)
  • Pathology (1427)
  • Pharmacology and Toxicology (2489)
  • Physiology (3729)
  • Plant Biology (8076)
  • Scientific Communication and Education (1437)
  • Synthetic Biology (2220)
  • Systems Biology (6036)
  • Zoology (1252)